Form 8-K - Current report:
SEC Accession No. 0000805928-25-000112
Filing Date
2025-08-25
Accepted
2025-08-25 06:41:48
Documents
14
Period of Report
2025-08-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K - FDA BLA UPDATE axgn-20250822.htm   iXBRL 8-K 29153
2 EX-99.1 - PRESS RELEASE ex991axgnpressreleasedated.htm EX-99.1 11642
6 AXGN LOGO image_0a.jpg GRAPHIC 30876
  Complete submission text file 0000805928-25-000112.txt   203513

Data Files

Seq Description Document Type Size
3 IXBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axgn-20250822.xsd EX-101.SCH 1788
4 IXBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axgn-20250822_lab.xml EX-101.LAB 21629
5 IXBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axgn-20250822_pre.xml EX-101.PRE 12512
16 EXTRACTED XBRL INSTANCE DOCUMENT axgn-20250822_htm.xml XML 2709
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)